C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2001
11/22/2001	WO2001087813A1 Process for producing cinnamylaldehyde derivatives, use thereof and the like
11/22/2001	WO2001032691A8 Hcv ns3 protease inhibitors
11/22/2001	US20010044521 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics
11/22/2001	US20010044415 Inhibition of apoptosis using interleukin-1B-converting enzyme (ICE)/CED-3 family inhibitors
11/22/2001	US20010044127 Method for isotope labeling of protein with enzyme
11/22/2001	CA2409445A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/21/2001	EP1156330A2 Method for isotope labeling of protein with enzyme
11/21/2001	EP1156059A1 Selectively cleavable linkers based on a methionine group and an ester group
11/21/2001	EP1155033A1 Process for preparing a stable non-hygroscopic crystalline n-[n-[n-(piperdin-4-yl)butanoyl)-n-ethylglycyl]-(l)-aspartyl]-ss-cyclohexylalanine amide
11/21/2001	EP1155032A1 N- n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester agglomerate
11/21/2001	EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
11/21/2001	EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/21/2001	EP0675898B1 Use of molecularly imprinted polymers for stereo- and/or regioselective synthesis
11/21/2001	EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001	CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001	CN1323315A 5-membered ring compounds
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323313A Process for the preparation of resin-bound cyclic peptides
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/21/2001	CN1074926C Antiarrhythmic benzodiazepines
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6320024 Method for design of substances that enhance memory and improve the quality of life
11/20/2001	US6319902 Peptide derivatives having thiazolyl-alanine residue
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	CA2156390C Technetium-99m labeled peptides for diagnostic imaging
11/20/2001	CA2008116C Glycine derivatives
11/15/2001	WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001	WO2001085977A2 Chemoenzymatic synthesis of neotame
11/15/2001	WO2001085930A2 Methods and compounds for modulating melanocortin receptor ligand binding and activity
11/15/2001	WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
11/15/2001	WO2001085761A1 Process for producing aspartyl dipeptide ester derivatives
11/15/2001	WO2001085760A1 Thrombin inhibitors
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	US20010041789 Alcoholism therapy
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	CA2408652A1 A method for designing and screening random libraries of compounds
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/14/2001	EP1153926A2 3,5-Dioxa-12-aza wurtzitane compound as molecular recognition agent and process of preparing same
11/14/2001	EP1153034A1 Growth hormone secretagogues
11/14/2001	EP1152770A1 Small peptides and methods for treatment of asthma and inflammation
11/14/2001	EP0847400B1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
11/14/2001	EP0799052B1 New antithrombotic formulation, process for its manufacturing, and use thereof
11/13/2001	US6316657 Process for purification or recovery of sweetener
11/13/2001	US6316595 PNA synthesis using a base-labile amino protecting group
11/13/2001	US6316496 For therapy of retroviral infection; prophylaxis of replication of retrovirus, therapy of aids (acquired immune deficiency syndrome)
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/13/2001	US6316413 Peptide agonists of bradykinin B2 receptor
11/13/2001	US6316405 Cyclosporin a conjugates and uses therefor
11/08/2001	WO2001083770A2 Lipolytic enzyme variant
11/08/2001	WO2001083761A1 Laccase mutants
11/08/2001	WO2001083559A2 Production and use of protein variants having modified immunogenecity
11/08/2001	WO2001083517A1 Stat4 and stat6 binding dipeptide derivatives
11/08/2001	WO2001083439A2 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
11/08/2001	WO2001083436A2 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
11/08/2001	WO2001040180A3 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
11/08/2001	WO2000033888A3 Prodrug compounds and process for preparation thereof
11/08/2001	US20010039357 N-alkylaspartyl dipeptide ester compounds
11/08/2001	US20010039274 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	CA2406621A1 Protein variants having modified immunogenicity
11/07/2001	EP1150998A1 Process for the preparation of cyclic tetrapeptide derivatives
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/07/2001	EP1150976A1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
11/07/2001	EP1150957A1 N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
11/07/2001	EP0546108B1 Pro-drugs for cck antagonists
11/07/2001	CN1321166A Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism
11/06/2001	US6313345 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/06/2001	US6313140 Method of treatment using certain growth-hormone secret agogues
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001	US6313109 Prenyl transferase inhibitors
11/06/2001	US6313097 Treatment or prophylaxis of migraine or cluster headaches, non-insulin-dependent diabetes mellitus, inflammation, allergic rhinitis, asthma, morphine tolerance, menopausal hot flashes, diseases characterized by excessive vasodilatation
11/06/2001	US6313096 Inhibitors of trypsin-like enzymes
11/06/2001	US6313095 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
11/06/2001	US6313094 Composition for inhibiting human immunodeficiency virus replication
11/06/2001	US6312734 Forming an oxidized glutatione complex with platinum or palladium
11/01/2001	WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides
11/01/2001	WO2001081369A2 Peptide potentiation of acid-sensory ion channel in pain
11/01/2001	WO2001081368A2 Blood-pressure reducing polypeptides containing vpp derived from microorganisms
11/01/2001	WO2001081366A2 Purification of ace inhibiting polypeptides containing vpp from milk
11/01/2001	WO2001081325A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/01/2001	WO2001081321A1 Method for producing 2,5-diketopiperazines, 2,5-diketopiperazines, dipeptides and the use thereof
11/01/2001	WO2001029066A3 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
11/01/2001	WO2001014318A3 New effectors of dipeptidyl peptidase iv for topical use
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	US20010036921 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/01/2001	CA2407376A1 Peptide potentiation of acid-sensory ion channel in pain
11/01/2001	CA2406532A1 Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties
10/2001
10/31/2001	EP1149843A1 Substituted phenethylamine derivatives
10/31/2001	EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001	EP1001799B1 Pharmaceutical composition containing peptichemio
10/31/2001	EP0833652A4 Novel kappa receptor selective opioid peptides
10/31/2001	EP0723454B1 Novel tripeptides useful in immune and cns therapy
10/31/2001	DE10008089A1 Production of tubulysin compounds comprises multi-stage process including condensation of N-methylpipecolinoyl-isoleucine with substituted thiazole-4-carboxylic acid derivative
10/30/2001	US6310273 Inhibiting apoptosis in plants using a baculovirus p35 protease inhibitor gene
10/30/2001	US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 307